Senior insider sale
Chief Financial Officer at ACADIA PHARMACEUTICALS INC — senior position signals high conviction
$557.3K
22K shares
What this filing means
SCHNEYER MARK C. plans to sell 22K shares of ACADIA PHARMACEUTICALS INC valued at approximately $557.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2025ACC: 0001967940-25-000057
Officer· Chief Financial Officer
Since Dec 2021
22K
Shares to sell
$557.3K
Approx. market value
22K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Compensation
NA
11/17/2023
22KTotal acquired22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/17/2023 | Compensation NA | 22K | — |
| Total | 22K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
22K
Market value
$557.3K
8/18/2025
Total
Units
22K
Value
$557.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/18/2025 | 22K | $557.3K | NASDAQ | Planned |
| Total | 22K | $557.3K | ||